These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10474077)

  • 1. In vivo receptor occupancy and plasma concentration of pranidipine, a potent and long-acting dihydropyridine calcium antagonist.
    Yamada S; Uchida S; Urayama A; Kimura R
    Pharmacology; 1999 Oct; 59(4):171-82. PubMed ID: 10474077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor occupation and plasma concentration of NKY-722, a water-soluble dihydropyridine-type calcium antagonist, in spontaneously hypertensive rats.
    Uchida S; Yamada S; Ohkura T; Heshikiri M; Yoshimi A; Shirahase H; Kimura R
    Br J Pharmacol; 1995 Jan; 114(1):217-23. PubMed ID: 7712021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo receptor binding of benidipine and amlodipine in mesenteric arteries and other tissues of spontaneously hypertensive rats.
    Yamada S; Nakajima M; Kusaka T; Uchida S; Kimura R
    Life Sci; 2002 Mar; 70(17):1999-2011. PubMed ID: 12148692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo measurement of 1,4-dihydropyridine receptors in mesenteric arteries of spontaneously hypertensive rats and effect of nifedipine and cilnidipine.
    Nakajima M; Yamada S; Uchida S; Kimura R
    Biol Pharm Bull; 2002 Jan; 25(1):24-8. PubMed ID: 11824551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor occupation and pharmacokinetics of MPC-1304, a new Ca2+ channel antagonist, in spontaneously hypertensive rats.
    Nozawa Y; Miyake H; Yamada S; Uchida S; Ohkura T; Kimura R
    Eur J Pharmacol; 1995 Dec; 287(2):191-6. PubMed ID: 8749035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sustained occupancy in vivo of cardiovascular calcium antagonist receptors by mepirodipine and its relation to pharmacodynamic effect in spontaneously hypertensive rats.
    Yamada S; Matsuoka Y; Kato Y; Kimura R; Inagaki O
    J Pharmacol Exp Ther; 1992 Aug; 262(2):589-94. PubMed ID: 1323654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors.
    Yamada S; Sugimoto N; Uchida S; Deguchi Y; Kimura R
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):466-72. PubMed ID: 7515992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vivo binding of (+)-[3H]PN 200-110 to peripheral tissues and brain of spontaneously hypertensive rats: effect of lacidipine.
    Mennini T; Taddei C; Uslenghi A; Cagnotto A; Micheli D; Trist D; Gaviraghi G; Ratti E
    J Pharm Pharmacol; 1993 May; 45(5):430-3. PubMed ID: 8099961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the plasma concentration of mepirodipine and its occupancy of Ca2+ antagonist receptors in rats.
    Yamada S; Matsuoka Y; Kimura R
    Pharm Res; 1993 Sep; 10(9):1346-9. PubMed ID: 8234175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists.
    Uchida S; Yamada S; Nagai K; Deguchi Y; Kimura R
    Life Sci; 1997; 61(21):2083-90. PubMed ID: 9395249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo specific binding characteristics and pharmacokinetics of a 1,4-dihydropyridine calcium channel antagonist in the senescent mouse brain.
    Uchida S; Yamada S; Deguchi Y; Yamamoto M; Kimura R
    Pharm Res; 2000 Jul; 17(7):844-50. PubMed ID: 10990204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of lacidipine with its receptor binding site supports a slow onset and long duration of action.
    Graziani F; Ratti E; van Amsterdam FT
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):290-6. PubMed ID: 8720430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential properties of the optical-isomers of pranidipine, a 1,4-dihydropyridine calcium channel modulator.
    Hirano T; Mori T; Kido M; Toide K; Ohura M; Fujiki H; Orito K; Yoshida K; Ikezono K; Sumida T; Nakayama N; Yabuuchi Y
    Fundam Clin Pharmacol; 1999; 13(6):650-5. PubMed ID: 10626752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects.
    Hashimoto K; Shirafuji T; Sekino H; Matsuoka O; Sekino H; Onnagawa O; Okamoto T; Kudo S; Azuma J
    Eur J Clin Pharmacol; 1998; 54(9-10):753-60. PubMed ID: 9923580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of the potent and long-lasting antihypertensive action of the new calcium channel blocker pranidipine. Evidence for strong affinity to the calcium channels or membranes.
    Miyakoda G; Nakayama N; Matsui K; Yabuuchi Y
    Arzneimittelforschung; 1995 Apr; 45(4):471-5. PubMed ID: 7779144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of dihydropyridine binding sites in the rat brain: hypertension and age-dependent modulation of [3H](+)-PN 200-110 binding.
    Huguet F; Huchet AM; Gerard P; Narcisse G
    Brain Res; 1987 May; 412(1):125-30. PubMed ID: 2955850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologically relevant receptor binding characteristics and 5alpha-reductase inhibitory activity of free Fatty acids contained in saw palmetto extract.
    Abe M; Ito Y; Oyunzul L; Oki-Fujino T; Yamada S
    Biol Pharm Bull; 2009 Apr; 32(4):646-50. PubMed ID: 19336899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in receptor binding affinity for nimodipine in the rat brain with permanent occlusion of bilateral carotid arteries.
    Yamada S; Uchida S; Naito T; Urayama A; Kimura R; Murakami Y; Matsumoto K; Watanabe H
    Life Sci; 2000 Feb; 66(14):1351-7. PubMed ID: 10755471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine myocardial dihydropyridine binding sites: a positron emission tomographic study with the calcium channel inhibitor 11C-S11568.
    Valette H; Crouzel C; Syrota A; Fuseau C; Bourachot ML
    Life Sci; 1994; 55(19):1471-7. PubMed ID: 7968214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.